Literature DB >> 3555466

The cystatins: a diverse superfamily of cysteine peptidase inhibitors.

A J Barrett.   

Abstract

The cystatins comprise a homologous group of protein inhibitors of peptidases, of which the first to be studied in detail was chicken cystatin from egg-white. Three distinct protein families or "types" are recognized within the cystatin superfamily. The type 1 cystatins (also called "stefins") are the simplest in structure, being single chains of about 100 amino acids, with no disulphide bonds or carbohydrate. The Type 2 cystatins, which include the egg-white protein, have about 115 amino acids, and two disulphide loops, but still no carbohydrate. The Type 3 cystatins are the plasma kininogens in which each molecule contains three divergent copies of the typical cystatin sequence differing in activity as well as structure; these complex inhibitor molecules contain disulphide bonds and also carbohydrate groups. The cystatins inhibit most cysteine endopeptidases of the papain type, and also the exopeptidase dipeptidyl peptidase I. Each cystatin molecule has a single reactive site for all the peptidases it inhibits, but there are large differences in K(i) values for different combinations of cystatin and enzyme, and calpains are inhibited only by one of the segments of the kininogens. The cystatins have many important characteristics in common, but their differences in molecular structure imply different routes of biosynthesis, are associated with different in vivo distributions, and suggest a variety of physiological functions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3555466

Source DB:  PubMed          Journal:  Biomed Biochim Acta        ISSN: 0232-766X


  39 in total

1.  Identification of a myeloid-derived suppressor cell cystatin-like protein that inhibits metastasis.

Authors:  Angela M Boutté; David B Friedman; Matthew Bogyo; Yongfen Min; Li Yang; P Charles Lin
Journal:  FASEB J       Date:  2011-04-25       Impact factor: 5.191

Review 2.  Protein inhibitors of proteinases from brain.

Authors:  T Akopyan
Journal:  Neurochem Res       Date:  1991-05       Impact factor: 3.996

3.  Cathepsin L and cystatin B gene expression discriminates immune coelomic cells in the leech Theromyzon tessulatum.

Authors:  Christophe Lefebvre; Franck Vandenbulcke; Béatrice Bocquet; Aurélie Tasiemski; Annie Desmons; Mathilde Verstraete; Michel Salzet; Claude Cocquerelle
Journal:  Dev Comp Immunol       Date:  2007-12-26       Impact factor: 3.636

4.  Glycation of Liver Cystatin: Implication on its Structure and Function.

Authors:  Mir Faisal Mustafa; Bilqees Bano
Journal:  J Fluoresc       Date:  2016-06-28       Impact factor: 2.217

5.  Bioinformatics and expression analyses of the Ixodes scapularis tick cystatin family.

Authors:  Adriana Mércia Guaratini Ibelli; Meghan M Hermance; Tae Kwon Kim; Cassandra Lee Gonzalez; Albert Mulenga
Journal:  Exp Appl Acarol       Date:  2012-10-10       Impact factor: 2.132

6.  Cystatin capture enzyme-linked immunosorbent assay for serodiagnosis of human clonorchiasis and profile of captured antigenic protein of Clonorchis sinensis.

Authors:  T Y Kim; S Y Kang; S H Park; K Sukontason; K Sukontason; S J Hong
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

7.  Crystal structure of tarocystatin-papain complex: implications for the inhibition property of group-2 phytocystatins.

Authors:  Ming-Hung Chu; Kai-Lun Liu; Hsin-Yi Wu; Kai-Wun Yeh; Yi-Sheng Cheng
Journal:  Planta       Date:  2011-03-18       Impact factor: 4.116

8.  Bilirubin binding with liver cystatin induced structural and functional changes.

Authors:  Mir Faisal Mustafa; Bilqees Bano
Journal:  J Fluoresc       Date:  2014-04-08       Impact factor: 2.217

Review 9.  Molecular background of progressive myoclonus epilepsy.

Authors:  Anna-Elina Lehesjoki
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

10.  Serum cystatin C level, kidney disease markers, and incidence of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Michael D Knudtson; Kristine E Lee; Barbara E K Klein
Journal:  Arch Ophthalmol       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.